Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of BPTH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bio-Path Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Bio-Path Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Bio-Path Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20253:33 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%436.3K shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:26 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%613.8K shares | New | Dec 31, 2024 | SEC |
| Nov 13, 2024 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 6, 2024 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Apr 3, 2024 | Intracoastal Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 2, 2024 | Hudson Bay Capital Management LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bio-Path Holdings, Inc. shares.
No Form 144 notices for Bio-Path Holdings, Inc. are on file.